Drug Trial Radar · NCT01051661
Safety and Efficacy of H1N1 Vaccines in Children Aged 6 Months to Less Than 10 Years of Age
Last checked: Nov 20, 2026Latest source record: Feb 26, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
6,154
Actual
Start
Feb 12, 2010
Primary completion
Aug 31, 2011
Study completion Sep 9, 2011
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Jan 18, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 6 months, up to 9 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to characterize the safety and efficacy of GSK Biologicals' H1N1 flu candidate vaccines GSK2340274A and GSK2340273A in children 6 months to less than 10 years of age.
Conditions
- Influenza
Interventions
GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations)Biological
Intramuscular injection, one or two doses
GSK Biologicals' investigational vaccine GSK2340273A (alternative formulations)Biological
Intramuscular injection, two doses
PlaceboBiological
Intramuscular injection, one dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects Reporting at Least One A/California Influenza EventTime frame: From 14 days after first vaccination until study conclusion on Day 385
Locations
17 sites in 8 countries. Site status is shown where the registry gives one.
GSK Investigational Site
Kippa-Ring, Queensland, Australia
GSK Investigational Site
Carlton, Victoria, Australia
GSK Investigational Site
São Paulo, Brazil
GSK Investigational Site
São Paulo, Brazil
GSK Investigational Site
Florianópolis, Santa Catarina, Brazil
GSK Investigational Site
Cali, Colombia
GSK Investigational Site
San José, Costa Rica
GSK Investigational Site
Durango, Mexico
GSK Investigational Site
Mexico City, Mexico
GSK Investigational Site
Monterrey, Mexico
GSK Investigational Site
Cuernavaca, Morelos, Mexico
GSK Investigational Site
City of Muntinlupa, Philippines
GSK Investigational Site
Dasmariñas, Cavite, Philippines
GSK Investigational Site
Sampaloc, Manila, Philippines
GSK Investigational Site
Singapore, Singapore
GSK Investigational Site
Bangkok, Thailand
GSK Investigational Site
Khon Kaen, Thailand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.